id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3536-0006,FDA,FDA-2024-E-3536,Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV–ICD,Notice,Determinations,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,,2026-02-06T20:29:55Z,2026-02383,0,0,09000064b9195b55
FDA-2024-E-3536-0005,FDA,FDA-2024-E-3536,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-25T02:48:25Z,,0,0,09000064b908e3f1
FDA-2024-E-3536-0004,FDA,FDA-2024-E-3536,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-09-22T04:00:00Z,2025,9,2025-09-22T04:00:00Z,,2025-09-22T23:26:10Z,,0,0,09000064b8fd20ed
FDA-2024-E-3536-0003,FDA,FDA-2024-E-3536,Letter from FDA CDER to U. S. Patent and Trademark Office,Other,Letter(s),2025-06-30T04:00:00Z,2025,6,2025-06-30T04:00:00Z,,2025-06-30T19:59:02Z,,0,0,09000064b8e31def
FDA-2024-E-3536-0002,FDA,FDA-2024-E-3536,"Patent Extension Application from Shumaker & Sieffert, P.A. (on behalf of Medtronic, Inc. (""Medtronic""))",Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T17:43:26Z,,0,0,090000648660b1c0
FDA-2024-E-3536-0001,FDA,FDA-2024-E-3536,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T17:41:26Z,,0,0,090000648660b1bf